What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“Due to both the helpfulness of my lab members and the weekly CaNCURE seminars, I have gained a strong understanding of my research and see the possible applications of this work in the cancer nanomedicine industry. CaNCURE has provided an all-encompassing co-op experience, helping me not only to see the implications of the research with which I’m involved, but also how to extend these ideas based on my own knowledge.”

Sonali Rodrigues, Behavioral Neuroscience, ’16


Trainee Spotlight


Catherine Nicholas

Health Science, '20

RHAMM splicing in multiple myeloma (MM) and its implications for immunotherapy

Ysaac Zegeye

Cell and Molecular Biology, '21

Using smart biomaterials with immunoadjuvants to treat metastatic breast cancer

Aviv Liani

Biology, '21

Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia

Featured Trainee Publication


Upcoming Events

Engineering Novel Nanoparticles to Enhance Chemotherapy for Local Recurrence and Distant Metastasis

Tuesday, September 24, 2019

Rong Liu, M.D., Ph.D., Department of Surgery, MGH Instructor in Surgery, Harvard Medical School

119 Snell Libary -- NEU, 3:25 PM


Mentor Spotlight


Judy Lieberman, M.D.

Chair in Cellular and Molecular Medicine ,

Studies how RNA interference regulates and dysregulates cell differentiation in order to develop new drugs to treat or prevent cancer. Students will characterize anti-cancer therapeutics comprised of membrane-anchored lipoproteins that are incorporated into siRNA-loaded lipid nanoparticles.


Anne Klibanski, M.D.

Physician in Medicine,,

Studies the pathogenesis and hormone regulation of pituitary tumors, with the goal of identifying more effective therapies for endocrine tumor treatment. Students will have the opportunity to test and validate new therapeutic strategies in vitro, as well as analyze clinical trial data.


Trainee Spotlight


Ysaac Zegeye

Cell and Molecular Biology, '21

Using smart biomaterials with immunoadjuvants to treat metastatic breast cancer

Sagi Ravid

Chemical Engg, '21

Enhanced delivery of camptothecin and doxorubicin conjugates with hyaluronic acid for the treatment of Glioblastoma using microbubble-mediated focused ultrasound

Catherine Nicholas

Health Science, '20

RHAMM splicing in multiple myeloma (MM) and its implications for immunotherapy


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...